Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pharmaceuticals

Items 1 to 10 of 3027 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 303
  1. Net price*
    Year
  2. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014

    GlobalData
    64 pages
    GlobalData's clinical trial report, “Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mucopolysac
    Englisch | Zukunftsanalyse | SKU: 403146
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Altea Therapeutics Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    20 pages
    Altea Therapeutics Corporation (Altea Therapeutics), formerly known as Altea Development Corporation is a pharmaceutical company that is engaged in the development and commercialization of transdermal patch technology, used to deliver therapeutic levels of water-soluble small drugs, therapeutic proteins, carbohydrates, and vaccines throu
    Englisch | Zukunftsanalyse | SKU: 345381
  4. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    NovImmune SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    24 pages
    NovImmune SA (NovImmune) is a biotechnology company. It discovers and develops therapeutic monoclonal antibodies for the treatment of immune-related disorders and inflammatory diseases. The company has developed seven monoclonal antibodies that are used for treating immune-related disorders. Its products include NI-0801, NI-0401, NI-0701,
    Englisch | Zukunftsanalyse | SKU: 163123
  5. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Liver Cirrhosis Global Clinical Trials Review, H1, 2013

    GlobalData
    95 pages
    Introduction GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H1, 2013" provides data on the Liver Cirrhosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cirrhosis. It includes an overview of the trial numbers and their recruitmen
    Englisch | Report | SKU: 330309
  6. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Renhe Pharmacy Co., Ltd. (000650) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of Renhe Pharmacy Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The pro
    Englisch | Zukunftsanalyse | SKU: 85428
  7. $4,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Rheumatoid Arthritis - Spain Drug Forecast and Market Analysis Event-Driven Update

    GlobalData
    128 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: Rheumatoid Arthritis - Spain Drug Forecast and Market Analysis Event-Driven Update”. The RA market is currently very dynamic, with the November 6, 2012 FDA approval of Pfizer’s Xeljanz (tofacitinib) and novel oral therapies awaiting approval such as: Eli Lill
    Englisch | Report | SKU: 329160
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Alopexx Pharmaceuticals, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    Alopexx Pharmaceuticals, LLC (Alopexx) is a pharmaceutical company. The company develops and commercializes products for the treatment and prevention of staphylococcal and other serious bacterial infections. Its product F598 is an intact fully human monoclonal antibody used against S. aureus and other clinically relevant bacteria. Alopexx
    Englisch | Zukunftsanalyse | SKU: 331072
  9. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Small Intestine Cancer Global Clinical Trials Review, H1, 2014

    GlobalData
    116 pages
    GlobalData's clinical trial report, “Small Intestine Cancer Global Clinical Trials Review, H1, 2014" provides data on the Small Intestine Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small Intestine Cancer. It includes an overview of the trial numbers and their re
    Englisch | Zukunftsanalyse | SKU: 403143
  10. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Mertiva AB (MERT MTF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    25 pages
    Mertiva AB (Mertiva) is a pharmaceutical company. It conducts operations through its wholly-owned subsidiary, Diamyd Medical AB. The company develops products for the treatment and prevention of autoimmune diabetes. The company’s lead drug is Diamyd (rhGAD65) and is under investigation for the treatment and prevention of type 1 diabetes
    Englisch | Zukunftsanalyse | SKU: 987673072
  11. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Corporativo Fragua S.A.B. de C.V. (FRAGUAB) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    Corporativo Fragua S.A.B. de C.V. (Corporativo Fragua) is a pharmaceutical company, operating chain of pharmacies in Mexico. Through its subsidiaries, the company is principally engaged in buying and selling of medicines, photography, house ware, perfumery, food, fruits and vegetables, bakery, and meat shop products. The company is also i
    Englisch | Zukunftsanalyse | SKU: 84781

Items 1 to 10 of 3027 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 303